Edition:
United States

Magforce AG (MF6G.F)

MF6G.F on Frankfurt Stock Exchange

5.12EUR
20 Jul 2018
Change (% chg)

€0.20 (+4.07%)
Prev Close
€4.92
Open
€4.78
Day's High
€5.12
Day's Low
€4.78
Volume
5,050
Avg. Vol
14,407
52-wk High
€8.35
52-wk Low
€4.46

Chart for

About

Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally;... (more)

Overall

Beta: 0.27
Market Cap(Mil.): €129.08
Shares Outstanding(Mil.): 26.34
Dividend: --
Yield (%): --

Financials

  MF6G.F Industry Sector
P/E (TTM): -- 217.69 33.34
EPS (TTM): -0.28 -- --
ROI: -46.53 -3.65 13.18
ROE: -51.76 -5.62 15.09

BRIEF-MagForce FY Stable Net Loss Of EUR 7.5 Mln

* FY REVENUES INCREASED TO EUR 716 THOUSAND COMPARED TO EUR 474 THOUSAND IN PREVIOUS YEAR

May 03 2018

BRIEF-Magforce Says Receives FDA Investigational Device Exemption Approval

* SAID ON SATURDAY RECEIVED FDA INVESTIGATIONAL DEVICE EXEMPTION APPROVAL TO CONDUCT A CLINICAL TRIAL WITH NANOTHERM THERAPY AS FOCAL ABLATION TREATMENT FOR INTERMEDIATE RISK PROSTATE CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Feb 12 2018

Earnings vs. Estimates